Table 1 Patient demographics and cyst characteristics.

From: Differentiation of Pancreatic Cyst Types by Analysis of Rheological Behavior of Pancreatic Cyst Fluid

Sample no.

Sex

Age (y)

Cyst dia. (mm)

Location

CEA (ng/mL)

Amylase (U/L)

Cytology

String sign

Flow curve type

Final diagnosis

Cyst type

1

Female

46

28

Tail

531

22

Negative

0

I

SC

NMC

2

Male

47

22

Body

49.8

61

Negative

0

III

Simple

NMC

3

Female

75

25

Body

9776

29

Positive

1

II

IPMN

MC

4

Female

68

22

Body

286.4

2896

Negative

0

I

IPMN

MC

5

Female

53

70

Head

24808

67

Positive

1

III

Cancer

MC

6

Female

52

50

Head

0.1

67483

Negative

0

I

SC

NMC

7

Female

21

35

Body

0.1

64

Negative

1

II

SC

NMC

8

Male

21

30

Head

0.1

68

Negative

1

II

SC

NMC

9

Female

59

33

Body

0.1

111

Negative

1

II

SC

NMC

10

Male

77

35

Head

2324

7060

Negative

1

III

IPMN

MC

11

Female

39

35

Body

22.2

107580

Negative

0

II

PC

PC

12

Male

53

26

Body

5.1

282240

Negative

0

II

PC

PC

13

Male

62

20

Body

32.8

27018

Positive

1

II

IPMN

MC

14

Female

58

45

Body

29

50162

Negative

0

II

PC

PC

15

Male

77

30

Body

2.4

118000

Negative

0

III

IPMN

MC

16

Male

53

35

Body

12.4

465

Negative

0

II

SC

NMC

17

Female

70

70

Tail

1.2

60

Negative

0

III

Cancer

MC

18

Male

55

70

Tail

1282

3833

Negative

0

II

PC

PC

19

Male

58

60

Body

18

184000

Negative

1

II

PC

PC

20

Male

56

40

Body

3271

491

Negative

0

III

Cancer

MC

21

Female

78

80

Tail

103970

33

Positive

0

III

Cancer

MC

22

Male

78

30

Body

7.6

737000

Negative

1

III

IPMN

MC

  1. SC - serous cystadenomas; MC - mucinous cyst; NMC - non-mucinous cyst; PC - pseudocyst; IPMN - intraductal papillary mucinous neoplasm. String sign = ‘1’, when there is a high likelihood of a mucinous cyst. Cytology was considered positive if the cytopathologist report included malignant (or suspicious) cells; otherwise, it was considered negative.